Taiyo study on prebiotics published

A clinical study published in European Review for Medical and Pharmacological Sciences looked at the role of Taiyo‘s prebiotic Sunfiber (PHGG) ingredient in reducing common cold symptoms. The placebo-controlled, double blind, randomized 12-week trial on 96 healthy adults revealed the prebiotic’s connection to gut and immune health. Participants received 5.2g of Sunfiber or a placebo. Journals of cold-like symptoms were kept, and levels of short-chain fatty acids (SCFAs) in stool and blood immune markers were taken at baseline and again at weeks 6 and 12. The Sunfiber group had a statistically significant greater number of cold symptom-free days, significant reduction in most general cold symptoms, general malaise, arthralgia, and chills, and reduction in constipation or diarrhea. 

TriNutra U.S. patent approved

TriNutra announced the approval of its U.S. patent demonstrating the synergistic effects of thymoquinone and omega-3 fatty acids for a healthy inflammation response. The U.S. patent protects TriNutra’s orally deliverable product, ThymoQuin, containing thymoquinone (TQ) from black seed oil (BSO) and thymoquinone from other resources, and omega-3 in different forms such as various mixtures of EPA and DHA in at least a 1:7 ratio. The synergistic effects have been tested in a preclinical study. Additionally, there has recently been a human study, indicating that the combination supports the immune system and overall well-being. The combination has also demonstrated support for a healthy microbiome. ThymoQuin is the first full-spectrum, cold-pressed, and standardized BSO to 3% TQ and very low free fatty acids (FFA). 

Gadot Biochemical predicts demand for zinc

Gadot Biochemical Industries predicts demand for zinc this winter season. The Israel-based supplier of zinc for dietary supplements and foods said it is ready to fulfill the product pipeline for the immune-support season. Gadot experienced growth in global mineral sales at the end of Q2 2022 over last year, according to Ohad Cohen, CEO. Cohen noted that rending claims of products containing zinc were in the plant-based category, with 600% growth in the last five years and 500% growth in herbal/botanical products with zinc. 

GFCO to be showcased at Expo East

The Gluten Intolerance Group (GIG) will be at Natural Products Expo East showcasing its Gluten-Free Certification Organization (GFCO) program, a gluten-free certification program with more than 60,000 products certified worldwide. In Booth #1504 at Expo East, GIG will share the benefits gluten-free natural products manufacturers are gaining by having products certified by GIG’s independent, third-party certification program, GFCO. Through its Cutting Costs program, the GIG Cares has teamed with GFCO-certified brands to provide monthly care packages full of certified gluten-free products to those in need. 

U.S. Pharmacopeia publishes findings

The United States Pharmacopeia (USP) published the Palm Oil Tocotrienols and Tocopherols Monograph in August, under Non-Botanical Dietary Supplements. The United States Pharmacopeia-National Formulary (USP-NF) is recognized as an official compendium of the United States by the Federal Food, Drug and Cosmetics Act (FFDCA). In general, USP Monograph sets the gold standard in the industry for a particular product or ingredient quality, strength, purity and safety. based on the USP Monograph, Palm Oil Tocotrienols and Tocopherols consist mainly of a mixture of α-, β-, γ-, and δ-tocotrienols and α-tocopherol derived from the oil from the mesocarp of fruits of Elaeis guineensis Jacq. (Family Arecaceae). β-, γ- and δ-tocopherols may be present in minor amounts. It also consists of phytosterols and squalene.

Solabia- Algatech Nutrition shares study results

Solabia- Algatech Nutrition released the results of a recently published clinical study demonstrating that AstaPure Arava can have a beneficial effect on immune health and well-being. There was significant reduction in the stress hormone cortisol and positive changes in the gut microbiome. The product is a full-spectrum microalgae complex, providing 3% astaxanthin, 50% polysaccharides and dietary fibers, 28% lipids, 14% proteins, and a variety of B-complex vitamins and trace minerals. The 32 participants completed a profile of mood state psychological assessment and a health log questionnaire assessing health status and URTCs, plus provided saliva and fecal samples for measurement of cortisol and microbiome balance. They reported significantly fewer URTC complaints—and better overall well-being. Further, symptoms like cough, sore throat, sniffles, and stuffiness were 78% lower compared to placebo, while the Global Mood State (i.e. overall well-being) was improved by 14%.

Euromed shares study for weight reduction

In a recently published clinical study, subjects supplementing with Euromed’s natural extract Pomanox showed significantly lower levels of hunger and a desire to eat, as well as higher levels of satiety, compared to a placebo group. In the preliminary, independent, placebo-controlled study conducted at Queen Margaret University, Edinburgh, 28 healthy participants were given either 3-week supplementation with Pomanox or a placebo. The results suggest that participants in the Pomanox group were more satisfied than those given the placebo. Participants were also less hungry after Pomanox intake during meals than those who consumed placebo juice and capsules. Scores from the visual analogue scales (VAS), which record subjective sensations, showed significantly lower levels of hunger and a desire to eat, as well as higher levels of fullness.

Open Book Extracts completes funding

Open Book Extracts (OBX) announced the completion of its Series C financing round. The funding secured could total between $20 million and $25 million. The second close of the round was led by the corporate venture unit of BAT – B tomorrow Ventures (BTV). The investment that includes other investors, will support ongoing research efforts at OBX, including toxicology, safety, and efficacy research on cannabinoid ingredients and finished products. In addition to the funding, OBX and BAT have signed a scientific collaboration agreement covering certain areas of future R&D. 

AlgaeCal Partners with Osteostrong

AlgaeCal announced its partnership with Osteostrong, the wellness franchise founded by CEO Kyle Zagrodzky. Osteostrong has 150 locations across North America. AlgaeCal’s Bone Builder pack, AlgaeCal Plus, and Triple Power Omega 3 Fish Oil supplements will be available to purchase in-center via branded display booth. This partnership launches in October in 10 beta stores in the U.S. and will expand into more locations in 2023. AlgaeCal has also created a specific email and phone number for Osteostrong and their members should they want to call in and talk to the brands Bone Health Consultants and learn more. 

RedLeaf granted SQF Level II certification

RedLeaf Biologics, Inc., announced it has successfully received SQF Level II certification for its manufacturing facility in Georgetown, KY. The SQF Program is administered by FMI, The Food Industry Association in the United States and is benchmarked to the Global Food Safety Initiative (GFSI), a global collection of standards and requirements for food companies to practice food safety management at the same high-quality standards around the world.